379 related articles for article (PubMed ID: 32854390)
1. Liquid Biopsy is Instrumental for 3PM Dimensional Solutions in Cancer Management.
Liskova A; Samec M; Koklesova L; Giordano FA; Kubatka P; Golubnitschaja O
J Clin Med; 2020 Aug; 9(9):. PubMed ID: 32854390
[TBL] [Abstract][Full Text] [Related]
2. Prostate cancer management: long-term beliefs, epidemic developments in the early twenty-first century and 3PM dimensional solutions.
Kucera R; Pecen L; Topolcan O; Dahal AR; Costigliola V; Giordano FA; Golubnitschaja O
EPMA J; 2020 Sep; 11(3):399-418. PubMed ID: 32843909
[TBL] [Abstract][Full Text] [Related]
3. The paradigm change from reactive medical services to 3PM in ischemic stroke: a holistic approach utilising tear fluid multi-omics, mitochondria as a vital biosensor and AI-based multi-professional data interpretation.
Golubnitschaja O; Polivka J; Potuznik P; Pesta M; Stetkarova I; Mazurakova A; Lackova L; Kubatka P; Kropp M; Thumann G; Erb C; Fröhlich H; Wang W; Baban B; Kapalla M; Shapira N; Richter K; Karabatsiakis A; Smokovski I; Schmeel LC; Gkika E; Paul F; Parini P; Polivka J
EPMA J; 2024 Mar; 15(1):1-23. PubMed ID: 38463624
[TBL] [Abstract][Full Text] [Related]
4. Energy metabolism as the hub of advanced non-small cell lung cancer management: a comprehensive view in the framework of predictive, preventive, and personalized medicine.
Bajinka O; Ouedraogo SY; Golubnitschaja O; Li N; Zhan X
EPMA J; 2024 Jun; 15(2):289-319. PubMed ID: 38841622
[TBL] [Abstract][Full Text] [Related]
5. Mass spectrometry analysis of human tear fluid biomarkers specific for ocular and systemic diseases in the context of 3P medicine.
Zhan X; Li J; Guo Y; Golubnitschaja O
EPMA J; 2021 Dec; 12(4):449-475. PubMed ID: 34876936
[TBL] [Abstract][Full Text] [Related]
6. Digital biomarkers: 3PM approach revolutionizing chronic disease management - EPMA 2024 position.
Smokovski I; Steinle N; Behnke A; Bhaskar SMM; Grech G; Richter K; Niklewski G; Birkenbihl C; Parini P; Andrews RJ; Bauchner H; Golubnitschaja O
EPMA J; 2024 Jun; 15(2):149-162. PubMed ID: 38841615
[TBL] [Abstract][Full Text] [Related]
7. Challenging management of severe chronic disorders in acute pandemic situation: Chronic liver disease under COVID-19 pandemic as the proof-of-principle model to orchestrate the measures in 3PM context.
Skladany L; Koller T; Adamcova Selcanova S; Vnencakova J; Jancekova D; Durajova V; Laffers L; Svac J; Janickova K; Palkovič M; Kohout P; Golubnitschaja O
EPMA J; 2021 Mar; 12(1):1-14. PubMed ID: 33680218
[TBL] [Abstract][Full Text] [Related]
8. All around suboptimal health - a joint position paper of the Suboptimal Health Study Consortium and European Association for Predictive, Preventive and Personalised Medicine.
Wang W; Yan Y; Guo Z; Hou H; Garcia M; Tan X; Anto EO; Mahara G; Zheng Y; Li B; Kang T; Zhong Z; Wang Y; Guo X; Golubnitschaja O;
EPMA J; 2021 Dec; 12(4):403-433. PubMed ID: 34539937
[TBL] [Abstract][Full Text] [Related]
9. Multi-faceted CRISPR/Cas technological innovation aspects in the framework of 3P medicine.
Lučanský V; Holubeková V; Kolková Z; Halašová E; Samec M; Golubnitschaja O
EPMA J; 2023 Jun; 14(2):201-217. PubMed ID: 37275547
[TBL] [Abstract][Full Text] [Related]
10. Mitochondriopathies as a Clue to Systemic Disorders-Analytical Tools and Mitigating Measures in Context of Predictive, Preventive, and Personalized (3P) Medicine.
Liskova A; Samec M; Koklesova L; Kudela E; Kubatka P; Golubnitschaja O
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33670490
[TBL] [Abstract][Full Text] [Related]
11. Predictive, preventive and personalised approach as a conceptual and technological innovation in primary and secondary care of inflammatory bowel disease benefiting affected individuals and populations.
Arosa L; Camba-Gómez M; Golubnitschaja O; Conde-Aranda J
EPMA J; 2024 Mar; 15(1):111-123. PubMed ID: 38463620
[TBL] [Abstract][Full Text] [Related]
12. Ischemic stroke of unclear aetiology: a case-by-case analysis and call for a multi-professional predictive, preventive and personalised approach.
Golubnitschaja O; Potuznik P; Polivka J; Pesta M; Kaverina O; Pieper CC; Kropp M; Thumann G; Erb C; Karabatsiakis A; Stetkarova I; Polivka J; Costigliola V
EPMA J; 2022 Dec; 13(4):535-545. PubMed ID: 36415625
[TBL] [Abstract][Full Text] [Related]
13. Promoting advanced medical services in the framework of 3PM-a proof-of-concept by the "Centro" Region of Portugal.
Regateiro FJ; Silva H; Lemos MC; Moura G; Torres P; Pereira AD; Dias L; Ferreira PL; Amaral S; Santos MAS
EPMA J; 2024 Mar; 15(1):135-148. PubMed ID: 38463621
[TBL] [Abstract][Full Text] [Related]
14. The Emergency Medical Team Operating System - a vision for field hospital data management in following the concepts of predictive, preventive, and personalized medicine.
Gaebel J; Schreiber E; Neumuth T
EPMA J; 2024 Jun; 15(2):405-413. PubMed ID: 38841618
[TBL] [Abstract][Full Text] [Related]
15. The economic burden of colorectal cancer across Europe: a population-based cost-of-illness study.
Henderson RH; French D; Maughan T; Adams R; Allemani C; Minicozzi P; Coleman MP; McFerran E; Sullivan R; Lawler M
Lancet Gastroenterol Hepatol; 2021 Sep; 6(9):709-722. PubMed ID: 34329626
[TBL] [Abstract][Full Text] [Related]
16. Systemic Effects Reflected in Specific Biomarker Patterns Are Instrumental for the Paradigm Change in Prostate Cancer Management: A Strategic Paper.
Golubnitschaja O; Kubatka P; Mazurakova A; Samec M; Alajati A; Giordano FA; Costigliola V; Ellinger J; Ritter M
Cancers (Basel); 2022 Jan; 14(3):. PubMed ID: 35158943
[TBL] [Abstract][Full Text] [Related]
17. Anti-prostate cancer protection and therapy in the framework of predictive, preventive and personalised medicine - comprehensive effects of phytochemicals in primary, secondary and tertiary care.
Mazurakova A; Samec M; Koklesova L; Biringer K; Kudela E; Al-Ishaq RK; Pec M; Giordano FA; Büsselberg D; Kubatka P; Golubnitschaja O
EPMA J; 2022 Sep; 13(3):461-486. PubMed ID: 35821883
[TBL] [Abstract][Full Text] [Related]
18. Significance of flavonoids targeting PI3K/Akt/HIF-1α signaling pathway in therapy-resistant cancer cells - A potential contribution to the predictive, preventive, and personalized medicine.
Mazurakova A; Koklesova L; Csizmár SH; Samec M; Brockmueller A; Šudomová M; Biringer K; Kudela E; Pec M; Samuel SM; Kassayova M; Hassan STS; Smejkal K; Shakibaei M; Büsselberg D; Saso L; Kubatka P; Golubnitschaja O
J Adv Res; 2024 Jan; 55():103-118. PubMed ID: 36871616
[TBL] [Abstract][Full Text] [Related]
19. Quality of life and cost-effectiveness of different breast cancer surgery procedures: a Markov decision tree-based approach in the framework of Predictive, Preventive, and Personalized Medicine.
Shi HY; Li CH; Chen YC; Chiu CC; Lee HH; Hou MF
EPMA J; 2023 Sep; 14(3):457-475. PubMed ID: 37605647
[TBL] [Abstract][Full Text] [Related]
20. Mediterranean diet in the targeted prevention and personalized treatment of chronic diseases: evidence, potential mechanisms, and prospects.
Xiao Y; Xiao X; Zhang X; Yi D; Li T; Hao Q; Zhang F; Li X; Wang N
EPMA J; 2024 Jun; 15(2):207-220. PubMed ID: 38841625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
